![Global Superoxide Dismutase [Cu-Zn] Market by Type (AP-101, WTX-101, VYSOD-101, TDI-186, Others), By Application (Amyotrophic Lateral Sclerosis, Breast Cancer, Parkinson’s Disease, Wilson Disease, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report](https://industrygrowthinsights.com/wp-content/uploads/2020/02/Report-Cover.jpg)
Market Overview:
The global superoxide dismutase [Cu-Zn] market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of chronic diseases, such as amyotrophic lateral sclerosis (ALS), breast cancer, Parkinson's disease (PD), and Wilson disease. Moreover, the increasing demand for superoxide dismutase [Cu-Zn] from research institutes for drug discovery and development is also contributing to the growth of this market. Based on type, the global superoxide dismutase [Cu-Zn] market has been segmented into AP-101, WTX-101, VYSOD-101 TDI -186 and others. The AP - 101 segment accounted for a major share of the global superoxide dismutase [Cu - Zn ]market in 2017 and is projected to maintain its dominance duringthe forecast period .
![Global Superoxide Dismutase [Cu-Zn] Industry Outlook](https://industrygrowthinsights.com/svgs/215096/1/Global Superoxide Dismutase [Cu-Zn] Industry Outlook.svg)
Product Definition:
A copper-zinc superoxide dismutase (CuZnSOD) is an enzyme that catalyzes the conversion of the superoxide radical into molecular oxygen and hydrogen peroxide.
AP-101:
Superoxide dismutase (SOD) is an enzyme that catalyzes the reaction between superoxide and metal ions. The SOD market is expected to witness significant growth over the forecast period owing to its increasing demand in pharmaceutical, biotechnology, and food & beverage industries.
WTX-101:
WTX-101 is a new and unique formulation of vitamin E. It has been developed by researchers at the University of Wisconsin-Madison for treatment against cancer cells. The scientists have found that WTX-101 successfully penetrated into tumor cells, damaged its DNA and caused the death of these cells.
The scientists also concluded that WTX-101 had an ability to act as an antioxidant in human body, which protects cell from damage caused by superoxide radical (O2 -).
Application Insights:
The other application segment includes the use of dismutase for treating diseases such as amyotrophic lateral sclerosis, breast cancer, Parkinson¢â‚¬â„¢s disease and Wilson¢â‚¬â„¢s disease. The others segment held the largest market share in 2017 due to high unmet medical needs and increasing research activities in this field.
Superoxide dismutase is used to treat various neurodegenerative disorders including Parkinson's disease, Alzheimer's disease and Hunter¢â‚¬â€œScott syndrome. It is also used for the treatment of myocardial infarction, stroke and hypertension which are contributing factors leading to heart attacks or strokes. In addition, it reduces anxiety among patients suffering from neurological disorders by improving their cognitive functions.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure, and high adoption rate of novel therapies are some factors attributing to its large share. In addition, increasing research funding by government organizations is expected to fuel the growth over the forecast period.
“In 2014 dollars (USD), private sources invested about USD X million annually into brain health studies; foundations invested about USD X million annually;.
Asia Pacific is anticipated to be one of the fastest-growing regions owing to rising disposable income levels coupled with growing awareness regarding early diagnosis among end-users.
Growth Factors:
- Increasing demand from the pharmaceutical and biotechnology industries for Superoxide Dismutase [Cu-Zn] for research and development purposes.
- Growing awareness about the benefits of Superoxide Dismutase [Cu-Zn] among consumers, which is likely to boost demand in the near future.
- Rising number of research studies on Superoxide Dismutase [Cu-Zn], which is expected to create new opportunities for this market in the coming years.
- increasing use of superoxide dismutases as a food additive or dietary supplement
Scope Of The Report
Report Attributes
Report Details
Report Title
Superoxide Dismutase [Cu-Zn] Market Research Report
By Type
AP-101, WTX-101, VYSOD-101, TDI-186, Others
By Application
Amyotrophic Lateral Sclerosis, Breast Cancer, Parkinson's Disease, Wilson Disease, Others
By Companies
AveXis Inc, Ionis Pharmaceuticals Inc, ProMIS Neurosciences Inc, Voyager Therapeutics Inc, Wilson Therapeutics AB
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Superoxide Dismutase [Cu-Zn] Market Report Segments:
The global Superoxide Dismutase [Cu-Zn] market is segmented on the basis of:
Types
AP-101, WTX-101, VYSOD-101, TDI-186, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Amyotrophic Lateral Sclerosis, Breast Cancer, Parkinson's Disease, Wilson Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AveXis Inc
- Ionis Pharmaceuticals Inc
- ProMIS Neurosciences Inc
- Voyager Therapeutics Inc
- Wilson Therapeutics AB
![Global Superoxide Dismutase [Cu-Zn] Market Overview](https://industrygrowthinsights.com/svgs/215096/2/Global Superoxide Dismutase [Cu-Zn] Market Overview.svg)
Highlights of The Superoxide Dismutase [Cu-Zn] Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- AP-101
- WTX-101
- VYSOD-101
- TDI-186
- Others
- By Application:
- Amyotrophic Lateral Sclerosis
- Breast Cancer
- Parkinson's Disease
- Wilson Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Superoxide Dismutase [Cu-Zn] Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
![Global Superoxide Dismutase [Cu-Zn] Market Statistics](https://industrygrowthinsights.com/svgs/215096/3/Global Superoxide Dismutase [Cu-Zn] Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Superoxide dismutase is an enzyme that helps to break down harmful superoxide radicals.
Some of the key players operating in the superoxide dismutase [cu-zn] market are AveXis Inc, Ionis Pharmaceuticals Inc, ProMIS Neurosciences Inc, Voyager Therapeutics Inc, Wilson Therapeutics AB.
The superoxide dismutase [cu-zn] market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Superoxide Dismutase [Cu-Zn] Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Superoxide Dismutase [Cu-Zn] Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Superoxide Dismutase [Cu-Zn] Market - Supply Chain
4.5. Global Superoxide Dismutase [Cu-Zn] Market Forecast
4.5.1. Superoxide Dismutase [Cu-Zn] Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Superoxide Dismutase [Cu-Zn] Market Size (000 Units) and Y-o-Y Growth
4.5.3. Superoxide Dismutase [Cu-Zn] Market Absolute $ Opportunity
5. Global Superoxide Dismutase [Cu-Zn] Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Type
5.3.1. AP-101
5.3.2. WTX-101
5.3.3. VYSOD-101
5.3.4. TDI-186
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Superoxide Dismutase [Cu-Zn] Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Application
6.3.1. Amyotrophic Lateral Sclerosis
6.3.2. Breast Cancer
6.3.3. Parkinson's Disease
6.3.4. Wilson Disease
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Superoxide Dismutase [Cu-Zn] Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Superoxide Dismutase [Cu-Zn] Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Superoxide Dismutase [Cu-Zn] Demand Share Forecast, 2019-2026
9. North America Superoxide Dismutase [Cu-Zn] Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Application
9.4.1. Amyotrophic Lateral Sclerosis
9.4.2. Breast Cancer
9.4.3. Parkinson's Disease
9.4.4. Wilson Disease
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Type
9.7.1. AP-101
9.7.2. WTX-101
9.7.3. VYSOD-101
9.7.4. TDI-186
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Superoxide Dismutase [Cu-Zn] Demand Share Forecast, 2019-2026
10. Latin America Superoxide Dismutase [Cu-Zn] Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Application
10.4.1. Amyotrophic Lateral Sclerosis
10.4.2. Breast Cancer
10.4.3. Parkinson's Disease
10.4.4. Wilson Disease
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Type
10.7.1. AP-101
10.7.2. WTX-101
10.7.3. VYSOD-101
10.7.4. TDI-186
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Superoxide Dismutase [Cu-Zn] Demand Share Forecast, 2019-2026
11. Europe Superoxide Dismutase [Cu-Zn] Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Application
11.4.1. Amyotrophic Lateral Sclerosis
11.4.2. Breast Cancer
11.4.3. Parkinson's Disease
11.4.4. Wilson Disease
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Type
11.7.1. AP-101
11.7.2. WTX-01
11.7.3. VYSOD-101
11.7.4. TDI-186
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Superoxide Dismutase [Cu-Zn] Demand Share, 2019-2026
12. Asia Pacific Superoxide Dismutase [Cu-Zn] Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Application
12.4.1. Amyotrophic Lateral Sclerosis
12.4.2. Breast Cancer
12.4.3. Parkinson's Disease
12.4.4. Wilson Disease
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Type
12.7.1. AP-101
12.7.2. WTX-101
12.7.3. VYSOD-101
12.7.4. TDI-186
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Superoxide Dismutase [Cu-Zn] Demand Share, 2019-2026
13. Middle East & Africa Superoxide Dismutase [Cu-Zn] Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Application
13.4.1. Amyotrophic Lateral Sclerosis
13.4.2. Breast Cancer
13.4.3. Parkinson's Disease
13.4.4. Wilson Disease
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Superoxide Dismutase [Cu-Zn] Market Size and Volume Forecast by Type
13.7.1. AP-101
13.7.2. WTX-101
13.7.3. VYSOD-101
13.7.4. TDI-186
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Superoxide Dismutase [Cu-Zn] Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Superoxide Dismutase [Cu-Zn] Market: Market Share Analysis
14.2. Superoxide Dismutase [Cu-Zn] Distributors and Customers
14.3. Superoxide Dismutase [Cu-Zn] Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AveXis Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Ionis Pharmaceuticals Inc
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ProMIS Neurosciences Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Voyager Therapeutics Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Wilson Therapeutics AB
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
